Informed-money record

ELVN · Enliven Therapeutics, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

124

Named actors

Disclosed $ (bull / bear)

$50K + 1 of unknown size / $188.4M + 5 of unknown size

Recent disclosures

25 of 127 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-10-01	Director Garland J. Scott	sold	$607K	SEC ↗
2026-10-01	Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) JEFFREY GARLAND	filed notice to sell	$607K	SEC ↗
2026-09-17	CHIEF MEDICAL OFFICER Collins Helen Louise	sold	$12K	SEC ↗
2026-09-17	CHIEF MEDICAL OFFICER Collins Helen Louise	sold	$146K	SEC ↗
2026-09-17	CHIEF MEDICAL OFFICER Collins Helen Louise	sold	$94K	SEC ↗

102 more disclosures in the window — the full record, scoring, and track-record evidence are for members.

Want the read, not just the record?

Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.

Start free — 1 week, no card →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals